Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Favrot

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Kidney International|August 1, 1991
Acute renal failure with preserved renal plasma flow induced by cancer immunotherapyA Mercatello, A Hadj-Aïssa, S Négrier, et al.
Medical and Pediatric Oncology|January 1, 1987
High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II studyC R Pinkerton, T Philip, P Biron, et al.
European Cytokine Network|August 1, 1990
Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapyM Favrot, R Capdeville, V Combaret, et al.
Clinical and Experimental Immunology|March 1, 1986
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrowG Janossy, H G Prentice, J P Grob, et al.
Clinical and Experimental Immunology|February 1, 1985
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDSG Janossy, A J Pinching, M Bofill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatmentG M Brodeur, J Pritchard, F Berthold, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE)R Erttmann, T Tafese, F Berthold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Early Human Development|September 20, 1996
A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observationsP Mathieu, D Frappaz, F Chauvin, et al.
Bone Marrow Transplantation|August 1, 1997
Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small childrenM Berger, J Kanold, C Rapatel, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Kidney International|August 1, 1991
Acute renal failure with preserved renal plasma flow induced by cancer immunotherapyA Mercatello, A Hadj-Aïssa, S Négrier, et al.
Medical and Pediatric Oncology|January 1, 1987
High-dose melphalan, vincristine, and total-body irradiation with autologous bone marrow transplantation in children with relapsed neuroblastoma: a phase II studyC R Pinkerton, T Philip, P Biron, et al.
European Cytokine Network|August 1, 1990
Functional and phenotypic modifications induced by IL-4, as single agent or in combination with IL-2, on PBMC preactivated in vivo by alpha-interferon + interleukin-2 therapyM Favrot, R Capdeville, V Combaret, et al.
Clinical and Experimental Immunology|March 1, 1986
T lymphocyte regeneration after transplantation of T cell depleted allogeneic bone marrowG Janossy, H G Prentice, J P Grob, et al.
Clinical and Experimental Immunology|February 1, 1985
An immunohistological approach to persistent lymphadenopathy and its relevance to AIDSG Janossy, A J Pinching, M Bofill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1993
Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatmentG M Brodeur, J Pritchard, F Berthold, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
10 years' neuroblastoma screening in Europe: preliminary results of a clinical and biological review from the Study Group for Evaluation of Neuroblastoma Screening in Europe (SENSE)R Erttmann, T Tafese, F Berthold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1988
International criteria for diagnosis, staging, and response to treatment in patients with neuroblastomaG M Brodeur, R C Seeger, A Barrett, et al.
Early Human Development|September 20, 1996
A 5-year (1990-1994) neuroblastoma screening feasibility study in France. Methodology and preliminary observationsP Mathieu, D Frappaz, F Chauvin, et al.
Bone Marrow Transplantation|August 1, 1997
Feasibility of a PB CD34+ cell transplantation procedure using standard leukapheresis products in very small childrenM Berger, J Kanold, C Rapatel, et al.
Pageof 7